mynth
← DATABASE
02/2020MinorityLBO

Amundi Private Equity & Societe Generale Capital Partenaires invest in Vivalto Vie

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV €100–350M

Context

Amundi PEF acquired a minority but leading stake in Vivalto Vie from Azulis Capital, which had been the group's largest shareholder since 2015 with approximately 35% of the capital. The sale process was mandated to Natixis Partners and Azulis Capital exited at a multiple exceeding 3x its initial investment. Société Générale Capital Partenaires entered the shareholder structure alongside Amundi PEF, while BNP Paribas Développement and Socadif retained small existing positions. Operational control of the group remains with Vivalto Partners. The transaction was financed through a unitranche facility provided by Ardian and a PIK instrument from CIC Private Debt and BNP Paribas PI, totalling €100 million, complemented by an €80 million capex line to support the group's development pipeline. Simultaneously with the LBO, Vivalto Vie completed the acquisition of Solimar in Spain, marking its first international expansion.

Vivalto Vie, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, standing directly in line with the average observed in the Healthcare & Pharma sector (14.6x in 2020).

-> Deep-dive in Healthcare & Pharma market trends

Target

Vivalto Vie is a French nursing home operator historically concentrated in the north-west of France, managing numerous facilities . A distinctive feature of Vivalto Vie is its property ownership model — the group owns its real estate assets, which significantly enhances its balance sheet value but also adds operational complexity in the context of a PE transaction. The group has embarked on a European expansion strategy, with Spain as its first international market.

Ent. Value

€100–350M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2019
€50–100M
€5–25M
[members only]
2018
€50–100M
€5–25M
[members only]

Other operations with Vivalto Vie

Other operations with Vivalto Vie
DateAcquirerTargetCountrySector
02/2020VIVALTO VIESOLIMARSPAINNursing Homes

Other operations with Amundi Private Equity / Societe Generale Capital Partenaires

Other operations with Amundi Private Equity / Societe Generale Capital Partenaires
DateAcquirerTargetCountrySector
05/2025AMUNDI PRIVATE EQUITY / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENTEDUSERVICESFRANCEEducation Providers
09/2019AMUNDI PRIVATE EQUITY / BPIFRANCE / SOCADIFWIFIRSTFRANCEOperators

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
06/2020ASKLEPIOS KLINIKENRHÖN-KLINIKUMGERMANYClinics / Hospitals
03/2020ORPEATLC GROUPIRELANDNursing Homes
02/2020CLARIANEINICEAFRANCEClinics / Hospitals
02/2020VIVALTO VIESOLIMARSPAINNursing Homes
01/2020ARDIANSANTE CIEFRANCEHealth Providers
01/2020VIVALTO SANTÉMATHILDE MÉDICAL DÉVELOPPEMENTFRANCEClinics / Hospitals
12/2019CIRCLE HEALTHBMI HEALTHCAREUNITED KINGDOMClinics / Hospitals
07/2019I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENTDOMIDEPFRANCENursing Homes
07/2019TRITON PARTNERSALERISSWEDENClinics / Hospitals
07/2019NAXICAP PARTNERS / ARDIANEMERAFRANCENursing Homes

REFERENCES

Valuation range: EV €100–350M

Revenue range: €50–100M

EBITDA range: €5–25M

EV/Revenue range: 2x - 6x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Vivalto Vie by Amundi Private Equity / Societe Generale Capital Partenaires are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: amundi private equity / societe generale capital partenaires

FAQ

What transaction does this page cover?

This page covers the acquisition of a minority stake in Vivalto Vie, a French company specialised in Healthcare Facilities, by Amundi Private Equity and Societe Generale Capital Partenaires in 2020, structured as a leveraged buyout (LBO).

How was the acquisition of Vivalto Vie by Amundi Private Equity valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €100–350M band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 2x - 6x range. Exact figures are available to members.

What were Vivalto Vie’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Vivalto Vie generated annual revenue estimated in the €50–100M range and EBITDA in the €5–25M bracket (FY 2019). Detailed financial figures are available to members.

How does the valuation of Vivalto Vie compare to benchmarks in the Healthcare & Pharma sector?

With an estimated multiple range of 10x - 18x, the transaction stands directly in line with historical averages for the Healthcare & Pharma sector (14.6x in 2020).

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.